Terminal Pathway Inhibitors for Neurodegenerative Disorders

Time: 3:00 pm
day: Track B - Day 1 PM


  • Terminal pathway inhibition facilitates regeneration
  • CP010, a humanized C6 antibody, is an effective C6 blocker in vivo
  • Systemic administration of CP010 prevents relapse in experimental autoimmune encephalomyelitis

Download the event guide here for full session details